On August 19, 2014,
CMS issued an alert addressing Section 111 reporting obligations and Medicare's
recovery of conditional payment claims in liability cases involving
alleged injuries due to exposure, ingestion, or implant prior to December 5,
1980. The alert clarifies that CMS will look to the dates alleged in the "most
recently amended operative complaint or comparable supplemental pleading" to
determine whether Section 111 reporting is required and whether Medicare will
seek recovery of conditional payment claims. The alert provides as
follows:
In the following
situations, Medicare will assert a recovery claim against settlements,
judgments, awards, or other payments, and the Medicare, Medicaid, and SCHIP
Extension Act of 2007 (MMSEA) Section 111 MSP mandatory reporting rules must be
followed:
- Exposure,
ingestion, or the alleged effects of an implant on or after December 5, 1980, is
claimed, released, or effectively released in the most recently amended
operative complaint or comparable supplemental pleading;
- A specified
length of exposure or ingestion is required for the claimant to obtain the
settlement, judgment, award, or other payment, and the claimant’s date of first
exposure plus the specified length of time in the settlement, judgment, award or other payment equals a date on or after
December 5, 1980. This also applies to implanted medical devices;
and
- A requirement
of the settlement, judgment, award, or other payment is that the claimant was
exposed to, or ingested, a substance on or after December 5, 1980. This rule
also applies if the settlement, judgment, award, or other payment depends on an
implant that was never removed or was removed on or after December 5, 1980.
When ALL
of the following criteria are met,
Medicare will not assert a recovery claim against a liability insurance
(including self-insurance) settlement, judgment, award, or other payment; and
MMSEA Section 111 MSP reporting is not required. (Note: Where multiple defendants are involved, the claimant must meet all of
these criteria for each individual defendant for a settlement, judgment, award,
or other payment from that defendant to be exempt from a potential MSP recovery
claim and MMSEA Section 111 reporting):
- All exposure or
ingestion ended or the implant was removed before December
5,1980;
- Exposure,
ingestion, or an implant on or after December 5, 1980, has not been claimed in
the most recently amended operative complaint (or comparable supplemental
pleading) and/or specifically released; and
- There is either
no release for the exposure, ingestion, or an implant on or after December 5,
1980, or where there is such a release, it is a broad general release (rather
than a specific release), which effectively releases exposure or ingestion on or
after December 5, 1980. The rule also applies if the broad general release
involves an implant.
Any operative amended complaint (or comparable
supplemental pleading) must occur prior to the date of settlement, judgment,
award, or other payment and must not have the effect of improperly shifting the
burden to Medicare by amending the prior complaint(s) to remove any claim for
medical damages, care, items and/or services, etc.
Where a complaint is amended by Court Order and that
Order limits Medicare’s recovery claim based on the criteria contained in this
alert, CMS will defer to the Order. CMS will not defer to Orders that contradict
governing MSP policy, law, or regulation.